Castle Biosciences Chief Commercial Officer W. Juvenal Tobin disposes of $232,140 in common shares
CSTL•Chief Commercial Officer Juvenal Tobin sold 6,577 Castle Biosciences shares on Sept. 29-30, 2026, for about $232,527; his reported stake afterward was 52,007 shares.
1. Share sales
Castle Biosciences Chief Commercial Officer Juvenal Tobin sold 6,577 common shares on Sept. 29-30, 2026. The sales totaled about $232,527, including 5,543 shares sold at a weighted-average price of $35.498; his reported stake after the Sept. 30 transaction was 52,007 shares.
